BioLineRx is trading at $2.36, up 6.79% before the October 8, 2026, market open; the reason for the move remains unclear.
- No clear company-specific announcement for October 8 appears in the available press-release listing.
- The investor-relations page highlights an upcoming GLIX1 presentation at EANO 2026.
- U.S. indices were lower, offering no clear explanation for the pre-market gain; no volume or trading-activity data was provided.